Publication Jun 1, 2017 Randomised Non-inferiority Trial: 1600 MG Versus 400 MG Tablets of Mesalazine for the Treatment of Mild-To-Moderate Ulcerative Colitis Geert D’Haens, Guangyong Zou, Vipul Jairath Read Now
Publication May 27, 2017 Histologic Scoring Indices for Evaluation of Disease Activity in Ulcerative Colitis Brian Feagan, Guangyong Zou, Vipul Jairath Read Now
Publication May 10, 2017 The Evolution of Treatment Paradigms in Crohn’s Disease: Beyond Better Drugs Brian Feagan, Vipul Jairath Read Now
Publication Mar 11, 2017 Incidence, Prevention and Management of Anti-Drug Antibodies Against Therapeutic Antibodies in Inflammatory Bowel Disease: A Practical Overview Brian Feagan, Vipul Jairath Read Now
Publication Mar 5, 2017 The Safety of Vedolizumab for the Treatment of Ulcerative Colitis Brian Feagan, Vipul Jairath Read Now
Publication Feb 5, 2017 Systematic Review With Meta-Analysis: Placebo Rates in Induction and Maintenance Trials of Crohn’s Disease Brian Feagan, Geert D’Haens, Guangyong Zou, Vipul Jairath Read Now
